These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9135698)

  • 1. The counterregulatory response to hypoglycaemia in women with the polycystic ovary syndrome.
    Gennarelli G; Holte J; Stridsberg M; Niklasson F; Berne C; Bäckström T
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):167-74. PubMed ID: 9135698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
    Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.
    Mumm H; Altinok ML; Henriksen JE; Ravn P; Glintborg D; Andersen M
    Hum Reprod; 2016 May; 31(5):1105-12. PubMed ID: 27008892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J; Bergh T; Gennarelli G; Wide L
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hypo- and hyperglycaemia on plasma leptin concentrations in healthy women and in women with polycystic ovary syndrome.
    Ludwig AK; Weiss JM; Tauchert S; Dietze T; Rudolf S; Diedrich K; Peters A; Oltmanns KM
    Hum Reprod; 2007 Jun; 22(6):1555-61. PubMed ID: 17395684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.
    Silfen ME; Denburg MR; Manibo AM; Lobo RA; Jaffe R; Ferin M; Levine LS; Oberfield SE
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4682-8. PubMed ID: 14557441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance.
    Robinson S; Chan SP; Spacey S; Anyaoku V; Johnston DG; Franks S
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):537-43. PubMed ID: 1424179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome.
    Fusco A; Bianchi A; Mancini A; Milardi D; Giampietro A; Cimino V; Porcelli T; Romualdi D; Guido M; Lanzone A; Pontecorvi A; De Marinis L
    J Endocrinol Invest; 2007 Dec; 30(11):948-56. PubMed ID: 18250617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
    Robinson S; Henderson AD; Gelding SV; Kiddy D; Niththyananthan R; Bush A; Richmond W; Johnston DG; Franks S
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):277-84. PubMed ID: 8729522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exaggerated glucagon responses to hypoglycemia in women with polycystic ovary syndrome.
    Sam S; Vellanki P; Yalamanchi SK; Bergman RN; Dunaif A
    Metabolism; 2017 Jun; 71():125-131. PubMed ID: 28521865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome?
    Gennarelli G; Holte J; Wide L; Berne C; Lithell H
    Hum Reprod; 1998 Mar; 13(3):535-41. PubMed ID: 9572406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The growth hormone response to growth hormone-releasing hormone is blunted in polycystic ovary syndrome: relationship with obesity and hyperinsulinaemia.
    Lanzone A; Villa P; Fulghesu AM; Pavone V; Caruso A; Mancuso S
    Hum Reprod; 1995 Jul; 10(7):1653-7. PubMed ID: 8582956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.
    Pasquali R; Gambineri A; Anconetani B; Vicennati V; Colitta D; Caramelli E; Casimirri F; Morselli-Labate AM
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):517-27. PubMed ID: 10468913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome.
    Faloia E; Canibus P; Gatti C; Frezza F; Santangelo M; Garrapa GG; Boscaro M
    J Endocrinol Invest; 2004 May; 27(5):424-9. PubMed ID: 15279073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
    Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.